DOI QR코드

DOI QR Code

Literature Review on Biological Effects of Gyejibokryeong-hwan against Gynaecological Diseases

  • Kim, Jung-Hoon (Basic Herbal Medicine Research Group, Korea Institute of Oriental Medicine) ;
  • Shin, Hyeun-Kyoo (Basic Herbal Medicine Research Group, Korea Institute of Oriental Medicine)
  • Received : 2013.05.02
  • Accepted : 2013.05.20
  • Published : 2013.06.30

Abstract

Objectives: To investigate therapeutic mechanisms of Gyejibokryeong-hwan (GJBRH) against gynaecological diseases, articles on biological assay were gathered and analyzed. Methods: The articles were classified as being from domestic or international journals, and by their year of publication. The mechanisms of the biological effects against gynaecological diseases were noted. Results: Of the 14 articles analyzed, 13 were published in China and 1 was from Japan. GJBRH showed therapeutic effect against uterine and mammary gland diseases. Uterine-related diseases such as endometriosis, hysteromyoma, adenomyosis, cancer, and inflammation can be improved by the administration of GJBRH through anti-angiogenesis, anti-inflammation, the modulation of immune cell and immunoglobulin, and the regulation of hormone secretion. GJBRH also reduced mammary hyperplasia by regulating hormone and cytokine release. Conclusions: We speculate that the inhibitory effect against uterine and mammary gland diseases could be related to the therapeutic efficacy of GJBRH in improving gynaecological diseases.

Keywords

References

  1. Professor association of herbal formula of Korea medicine. Herbal formula. Seoul:Youngrimsa. 2003:409.
  2. Western Pacific region of the World Health Organization. WHO international standard terminologies on traditional medicine in the western pacific region. World Health Organization. 2007:186.
  3. Sakamoto S, Yoshino H, Shirahata Y, Shimodairo K, Okamoto R. Pharmacotherapeutic effects of Kuei-chih-fu-ling-wan (Keishi-bukuryo-gan) on human uterine myomas. Am J Chin Med. 1992;20:313. https://doi.org/10.1142/S0192415X92000333
  4. Cho JH. A pilot study of the difference between Gyejibongnyeong-hwan and Gyejibongnyeong-hwan combined acupuncture therapy on the primary dysmenorrheal. J Orient Obstet. 2007;20(1):161-8.
  5. Choi G, Cho J, Jang J, Lee K. Clinical study on the efficacy of Gyejibongnyeong-hwan in the treatment of menorrhalgia. J Orient Obstet Gynecol. 2004;17(1):178-86.
  6. Zhang WJ, Wang ZN, Zheng H, Zheng PE, Ma BF, Zhuo LD. The role of Guizhifulingwan on angiogenesis of endometriosis model rat. J Jinan Univ, Nat Sci Med Ed. 2004;25(2):164-74.
  7. Liu HZ, Qiao FY, Chen SH, Lin XZ, Wang XR. Effects of Guizhifuling extracture on immune function in experimental rats with endometriosis. Herald of Medicine. 2005;124(17):566-8.
  8. Cai XT, Hu CP, Hu TT, Wang ZG, Cao P, Wang M. Effects of Guizhi Fuling capsule on the expression of MCP-1 and ICAM-1 mRNA of ectopic endometrium in rats with endometriotics. Chin J Exp Tradit Med Formulae. 2011;17(15):202-5.
  9. Hu CP, Hu TT, Cai XT, Wang ZG, Lu WG, Wan GP, at al. Effects of Guizhi Fuling capsule on quantity of CD4+ T lymphocytes and cytotoxic activity of NK cells in spleen of rats with endometriotics. Chin J Exp Tradit Med Formulae. 2011;17(9):145-8.
  10. Ji X, Gao J, Cai X, Lu W, Hu C, Wang, Z, et al. Immunological regulation of Chinese herb Guizhi Fuling Capsule on rat endometriosis model. J Ethnopharmacol. 2011;134:624-9. https://doi.org/10.1016/j.jep.2011.01.003
  11. Ling HY. Mechanism research on treatment of Guizhi Fuling pills for endometriosis in rats. Chin J Exp Tradit Med Formulae. 2012;18(23):270-3.
  12. Li L, Cheng GL, Gu FL, Wang YS. Preventive and cure effects of guizhi fuling Pellet on rat hysteromyoma models. Chin J Clin Pharmacol Ther. 2005;10(7):832-5.
  13. Liu C, Fu YQ, Wang Y, Wang H, Liu WJ, Wang ZH, et al. Effects of Guizhi Fuling pill and be taken apart on warming yang and diuretic promoting blood circulation and removing blood stasis in model of mice with hysteromyoma. Journal of Liaoning University of TCM. 2009;11(11):214-6.
  14. Mori T, Sakamoto S, Singtripop T, Park MK, Kato T, Kawashima S, et al. Suppression of spontaneous development of uterine adenomyosis by a Chinese herbal medicine, Keishi-Bukuryo-Gan, in mice. Planta Med. 1993;59:308-11. https://doi.org/10.1055/s-2006-959687
  15. Yao Z, Shulan Z. Inhibition effect of Guizhi-Fuling-decoction on the invasion of human cervical cancer. J Ethnopharmacol. 2008;120:25-35. https://doi.org/10.1016/j.jep.2008.07.044
  16. Shi W, Liu RF, Yang XN, Xu L. Effect of Guizhi Fuling capsule on the inflammatory cytokines in uterine tissue of the female rats with experimental pelvic inflammatory disease. Journal of Nanjing University of TCM. 2012;28(6):558-60.
  17. Jiang SH, Liu WG, Yang LP, Wang L, Wang XP, Wang DD. Therapeutic experimental study of Guizhifuling Capsule on hyperplasia of mammary glands in rats. Chinese Traditional Patent Medicine. 2004;26(12):1040-2.
  18. Liu HC, Liu WG, Yang LP. Effect of guizhi fuling capsule on the endocrine and immune function in rats with hyperplasia of mammary glands. Chin J Clin Rehabil. 2005;9(2):194-5.
  19. Zhu XX, Zhang ZH, Qiu ZJ, Jia MC. Experimental study of Guizhi Fuling capsule on cyclomastopathy rats. Modern Journal of Integrated Traditional Chinese and Western Medicine. 2006;15(5):571-6.
  20. Giudice LC. Endometriosis. N Engl J Med. 2010;362:2389-98. https://doi.org/10.1056/NEJMcp1000274
  21. Demirturk F, Aytan H, Caliskan AC, Aytan P, Koseoglu DR. Effect of peroxisome proliferator Activated receptor-$\gamma$ agonist rosiglitazone on the induction of endometriosis in an experimental rat model. J Soc Gynecol Investig. 2006;13(1):58-62. https://doi.org/10.1016/j.jsgi.2005.10.002
  22. Machado DE, Berardo PT, Palmero CY, Nasciutti LE. Higher expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) and metalloproteinase-9 (MMP-9) in a rat model of peritoneal endometriosis is similar to cancer diseases. J Exp & Clin Cancer Res. 2010;29(4):1-9. https://doi.org/10.1186/1756-9966-29-1
  23. He H, Ma XD. Expression and significance of MMP-2, MMP-9 and VEGF in endometriosis. Progress in Modern Biomedicine. 2009;9(21):4083-5.
  24. Katayama H, Katayama T, Uematsu K, Hiratsuka M, Kiyomura M, Shimizu Y, et al. Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model. Hum Reprod. 2010;25(11):2851-8. https://doi.org/10.1093/humrep/deq241
  25. Kim JH, Yang YI, Ahn JH, Lee JG, Lee KT, Choi JH. Deer (Cervus elaphus) antler extract suppresses adhesion and migration of endometriotic cells and regulates MMP-2 and MMP-9 expression. J Ethnopharmacol. 2012;140:391-7. https://doi.org/10.1016/j.jep.2012.01.032
  26. Malvezzi H, Aguiar VG, de Paz CCP, Tanus-Santos JE, de Araujo Penna IA, Navarro PA. Increased circulating MMP-2 levels in infertile patients with moderate and severe pelvicendometriosis. Reprod Sci. 2012;20(5):557-62.
  27. Bendrik C, Karlsson L, Dabrosin C. Increased endostatin generation and decreased angiogenesis via MMP-9 by tamoxifen in hormone dependent ovarian cancer. Cancer Lett. 2010;292:32-40. https://doi.org/10.1016/j.canlet.2009.11.002
  28. Koyama N, Matsuura K, Okamura H. Cytokines in the peritoneal fluid of patients with endometriosis. Int J Gynecol Obstet. 1993;43:45-50. https://doi.org/10.1016/0020-7292(93)90273-Y
  29. Tao Y, Zhang Q, Huang W, Zhu H, Zhang D, Luo W. The peritoneal leptin, MCP-1 and TNF-a in the pathogenesis of endometriosis-associated infertility. Am J Reprod Immunol. 2011;65:403-6. https://doi.org/10.1111/j.1600-0897.2010.00920.x
  30. Tran LVP, Tokushige N, Berbic M, Markham R, Fraser IS. Macrophages and nerve fibres in peritoneal endometriosis. Hum Reprod. 2009;24(4):835-41.
  31. Vigano P, Pardi R, Magri B, Busacca M, Di Blasio AM, Vignali M. Expression of intercellular adhesion molecule-1 (ICAM-1) on cultured human endometrial stromal cells and its role in the interaction with natural killers. Am J Reprod Immunol. 1994;32:139-45. https://doi.org/10.1111/j.1600-0897.1994.tb01104.x
  32. Vigano P, Infantino M, Lattuada D, Lauletta R, Ponti E, Somigliana E, et al. Intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms in endometriosis. Mol Hum Reprod. 2003;9:47-52. https://doi.org/10.1093/molehr/gag002
  33. Wu MH, Yang BC, Lee YC, Wu PL, Hsu CC. The differential expression of intercellular adhesion molecule-1 (ICAM-1) and regulation by interferon-gamma during the pathogenesis of endometriosis. Am J Reprod Immunol. 2004;51:373-80. https://doi.org/10.1111/j.1600-0897.2004.00171.x
  34. Berbic M, Fraser IS. Regulatory T cells and other leukocytes in the pathogenesis of endometriosis. J Reprod Immunol. 2011;88:149-55. https://doi.org/10.1016/j.jri.2010.11.004
  35. Itoh H, Uchida M, Sashihara T, Ji ZS, Li J, Tang Q, et al. Lactobacillus gasseri OLL2809 is effective especially on the menstrual pain and dysmenorrhea in endometriosis patients: randomized, double-blind, placebo-controlled study. Cytotechnology. 2011;63(2):153-61. https://doi.org/10.1007/s10616-010-9326-5
  36. Tanaka E, Sendo F, Kawagoe S, Hiroi M. Decreased natural killer cell activity in women with endometriosis. Gynecol Obstet Invest. 1992;34:27-30. https://doi.org/10.1159/000292720
  37. Ewington L, Taylor A, Sriraksa R, Horimoto Y, Lam EWF, El-Bahrawy MA. The expression of interleukin-8 and interleukin-8 receptors in endometrial carcinoma. Cytokine. 2012;59(2):417-22. https://doi.org/10.1016/j.cyto.2012.04.036
  38. Ohata Y, Harada T, Miyakoda H, Taniguchi F, Iwabe T, Terakawa N. Serum interleukin-8 levels are elevated in patients with ovarian endometrioma. Fertil Steril. 2008;90(4):994-9. https://doi.org/10.1016/j.fertnstert.2007.07.1355
  39. Altan ZM, Denis D, Kagan D, Grund EM, Palmer SS, Nataraja SG. A long-acting tumor necrosis factor $\alpha$-binding protein demonstrates activity in both in vitro and in vivo models of endometriosis. J Pharmacol Exp Therapeut. 2010;334:460-6. https://doi.org/10.1124/jpet.110.166488
  40. Braundmeier AG, Nowak RA. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer. Am J Reprod Immunol. 2006;56:201-14. https://doi.org/10.1111/j.1600-0897.2006.00418.x
  41. Li Z, Sun Y, Min W, Zhang D. Correlation between overexpression of transforming growth factor-beta 1 in occluded fallopian tubes and postsurgical pregnancy among infertile women. Int J Gynecol Obstet. 2011;112:11-4. https://doi.org/10.1016/j.ijgo.2010.07.016
  42. Berkkanoglu M, Arici A. Immunology and Endometriosis. Am J Reprod Immunol. 2003;50:48-59. https://doi.org/10.1034/j.1600-0897.2003.00042.x
  43. Gajbhiye R, Suryawanshi A, Khan S, Meherji P, Warty N, Raut V, et al. Multiple endometrial antigens are targeted in autoimmune endometriosis. Reprod Biomed Online. 2008;16(6):817-24. https://doi.org/10.1016/S1472-6483(10)60147-2
  44. Huang SH. Correlative study between endometriosis and immune infertility. Mod Diagn Treat. 2011;22(1):7-11.
  45. Kyama CM, Debrock S, Mwenda JM, D'Hooghe TM. Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol. 2003;1:123. https://doi.org/10.1186/1477-7827-1-123
  46. Chatenoud L, Salomon B, Bluestone JA. Suppressor T cells they're back and critical for regulation of autoimmunity. Immunol Rev. 2001;182:149-63. https://doi.org/10.1034/j.1600-065X.2001.1820112.x
  47. Szyllo K, Tchorzewski H, Banasik M, Glowacka E, Lewkowicz P, Kamer-Bartosinska A. The involvement of T lymphocytes in the pathogenesis of endometriotic tissues overgrowth in women with endometriosis. Mediators Inflamm. 2003;12(3):131-8. https://doi.org/10.1080/0962935031000134842
  48. Yang JB, Yang F. Effect of QuYiKang on TXB2 and 6-Keto-PGF1$\alpha$ of endometriosis in rats. Chinese Archives of Traditional Chinese Medicine. 2010;28(9):1881-3.
  49. Enzler M, Schipp S, Nicolas LB, Dingemanse J, Siethoff C. Determination of 6-keto prostaglandin F1$\alpha$ and its metabolites in human plasma by LC MS/MS. J Chromatogr B. 2012;901(15):67-71. https://doi.org/10.1016/j.jchromb.2012.05.044
  50. He K, Liu J, Li CX, Liu LH, Li Q. The Effect of Dan'e Fukang decocted extract on TXB2 and 6-keto-PGF1$\alpha$ of endometriosis rats. Drugs and Clinic. 2012;9(17):30-3.
  51. Paolo V, Paola S, Alberto P, Barbara M, Luca B, Giorgio PC. Mononuclear cell [beta]-endorphin concentration in women with and without endometriosis. Obstetrics & Gynecology. 1992;79(5):743-6.
  52. Rasmussen NA, Farr LA. Beta-endorphin response to an acute pain stimulus. J Neurosci Methods. 2009;177:285-8. https://doi.org/10.1016/j.jneumeth.2008.10.013
  53. Saadawi S, Jalil J, Jasamai M, Jantan I. Inhibitory effects of acetylmelodorinol, chrysin and polycarpol from Mitrella kentii on prostaglandin E2 and thromboxane B2 production and platelet activating factor receptor binding. Molecules. 2012;17:4824-35. https://doi.org/10.3390/molecules17054824
  54. Osada H, Silber S, Kakinuma T, Nagaishi M, Kato K, Kato O. Surgical procedure to conserve the uterus for future pregnancy in patients suffering from massive adenomyosis. Reprod Biomed Online. 2011;22(1):94-9. https://doi.org/10.1016/j.rbmo.2010.09.014
  55. Sakamoto S, Mori T, Singtripop T, Kawashima S, Suzuki S, Kudo H, et al. Increase of DNA synthesis in uterine adenomyosis in mice with ectopic pituitary isograft. Acta Anatomica. 1992;145:162-6. https://doi.org/10.1159/000147359
  56. Zhou YF, Mori T, Kudo H, Asakai R, Sassa S, Sakamoto S. Effects of angiogenesis inhibitor TNP-470 on the development of uterine adenomyosis in mice. Fertil Steril. 2003;80(Supplement 2):788-94. https://doi.org/10.1016/S0015-0282(03)00988-9
  57. Shintani M, Urano M, Takakuwa Y, Kuroda M, Kamoshida S. Immunohistochemical characteriz ation of pyrimidine synthetic enzymes, thymidine kinase-1 and thymidylate synthase, in various types of cancer. Oncol Rep. 2010;23(5):1345-50.
  58. Lee KH, Hur HS, Im SA, Lee J, Kim HP, Yoon YK, et al. RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase. Cancer Lett. 2010;299:22-8. https://doi.org/10.1016/j.canlet.2010.07.020
  59. The treatment of gynecological diseases. 2013;[1 screen]. Available at:URL:http://www.medicaltravel.ru/en/index.php?categoryid=20. Assessed Apr 10, 2013.
  60. Gu M, Liu GJ, Wang YF, Wang J. Experimental study of the effect Fengwangjiang on hysteromyoma in rat models. Journal of Hangzhou Teachers College (Medicine Edition). 2007;27(3):141-2.
  61. Hu SQ, Zheng HB, Wang XH. Effect of letrozole on the secretion of estradiol by hysteromyoma cells in vitro. Herald of Medicine. 2005;24(12):1101-3.
  62. Yin H. Effect of testosterone undecanoate combined with Gongliuqing on hysteromyoma of premenopause. Journal of Xinxiang Medicine College. 2011;28(4):506-8.
  63. Kleinberg DL, Ameri P, Singh B. Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia. Pituitary. 2011;14(1):44-52. https://doi.org/10.1007/s11102-010-0257-0
  64. Bocchinfuso WP, Hively WP, Couse JF, Varmus HE, Kor KS. A mouse mammary tumor Virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-$\alpha$. Cancer Res. 1999;59:1869-76.
  65. Milliken EL, Ameduri RK, Landis MD, Behrooz A, Abdul-Karim FW, Keri RA. Ovarian hyperstimulation by LH leads to mammary gland hyperplasia and cancer predisposition in transgenic mice. Endocrinology. 2002;143(9):3671-80. https://doi.org/10.1210/en.2002-220228
  66. Harvell DME, Strecker TE, Tochacek M, Xie B, Pennington KL, McComb RD, et al. Rat strain-specific actions of 17$\beta$-estradiol in the mammary gland: Correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers. PNAS. 2000;97(6):2779-84. https://doi.org/10.1073/pnas.050569097
  67. Sirotkovic-Skerlev M, Cacev T, Krizanac S, Kulic A, Pavelic K, Kapitanovic S. TNF alpha promoter polymorphisms analysis in benign and malignant breast lesions. Exp Mol Pathol. 2007;83(1):54-8. https://doi.org/10.1016/j.yexmp.2006.11.004
  68. Kamali-Sarvestania E, Merat A, Talei AR. Polymorphism in the genes of alpha and beta tumor necrosis factors (TNF-$\alpha$ and TNF-$\beta$) and gamma interferon (IFN-$\gamma$) among Iranian women with breast cancer. Cancer Lett. 2005;223:113-9. https://doi.org/10.1016/j.canlet.2004.09.025
  69. Garcia-Tunon I, Ricote M, Ruiz A, Fraile B, Paniagua R, Royuela M. Interleukin-2 and its receptor complex ($\alpha$, $\beta$ and $\gamma$ chains) in in situ and infiltrative human breast cancer: an immunohistochemical comparative study. Breast Cancer Res. 2004;6:R1-R7. https://doi.org/10.1186/bcr730
  70. Zhang W, Liu J, Guo X, Chen F. The effects of acupuncture on serum IL- 2 and TNF- A of rats with experimental mammary gland hyperplasia (MGH). Journal of Shaanxi College of TCM. 2008;31(4):53-4.

Cited by

  1. 말 태반 가수분해 추출물의 Sprague-Dawley Rat를 이용한 단회 경구투여 독성시험 vol.31, pp.1, 2014, https://doi.org/10.13045/acupunct.2014010
  2. 합곡, 수삼리 자하거약침요법을 병행한 복합 한방치료의 수부냉증 치험례 vol.31, pp.4, 2013, https://doi.org/10.14406/acu.2014.030
  3. 자하거 약침의 지표물질 선정 및 분석법 벨리데이션 vol.26, pp.1, 2013, https://doi.org/10.18325/jkmr.2016.26.1.33
  4. 계지복령환의 효능에 대한 국내외 실험연구 동향 분석 vol.29, pp.2, 2013, https://doi.org/10.15204/jkobgy.2016.29.2.099
  5. 신기능 장애를 동반한 급성 알코올성 간염 환자 치험 1예 vol.16, pp.2, 2016, https://doi.org/10.15429/jkomor.2016.16.2.138
  6. 한의약 치료로 FT4 수치에 개선을 보인 갑상선기능항진증 환자 1례에 관한 증례보고 vol.38, pp.4, 2017, https://doi.org/10.22246/jikm.2017.38.4.501
  7. Systematic Review of Hominis Placenta Pharmacopuncture in English and Korean Literature vol.34, pp.4, 2017, https://doi.org/10.13045/jar.2017.02236
  8. Apoptotic effect of Gyejibokryunghwan on uterine sarcoma cells (SK-UT-1B) vol.61, pp.None, 2019, https://doi.org/10.1016/j.phymed.2018.12.029